Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M104,246Revenue (TTM) $M37,776Net Margin (%)5.8Altman Z-Score1.4
Enterprise Value $M127,389EPS (TTM) $0.8Operating Margin %12.4Piotroski F-Score7
P/E(ttm)48.1Beneish M-Score-2.8Pre-tax Margin (%)10.1Higher ROA y-yY
Price/Book46.910-y EBITDA Growth Rate %-1.9Quick Ratio0.6Cash flow > EarningsY
Price/Sales2.85-y EBITDA Growth Rate %-8.5Current Ratio0.9Lower Leverage y-yY
Price/Free Cash Flow16.2y-y EBITDA Growth Rate %40.0ROA % (ttm)2.9Higher Current Ratio y-yN
Dividend Yield %4.6PEG--ROE % (ttm)132Less Shares Outstanding y-yN
Payout Ratio %226Shares Outstanding M2,459ROIC % (ttm)13.5Gross Margin Increase y-yY

Gurus Latest Trades with GSK

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

GSK is held by these investors:



GSK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner 2015-02-23Sell503,150$2298.18view
GLAXOSMITHKLINE PLC10% Owner 2014-12-18Sell50,000$21.14106.24view
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29724.2view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$12263.33view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$14211.43view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$12263.33view

Press Releases about GSK :

Quarterly/Annual Reports about GSK:

    News about GSK:

    Articles On GuruFocus.com
    Seth Klarman Backs Out of Innoviva Days After Activist Stakeholder Defeated May 10 2017 
    Pernix: An Investor's Rationale to Staying Long Mar 23 2017 
    Jeff Auxier Reduces, Exits Multiple Positions in 4th Quarter Mar 22 2017 
    Gilead Sciences Raises Dividend by Double Digits Feb 22 2017 
    If You Want Yield, Look to the UK Feb 19 2017 
    Flood of News Presents Buying Opportunity Jan 17 2017 
    Gilead Sciences Must Answer to Investors After a Disappointing 2016 Jan 05 2017 
    GlaxoSmithKline, Vodafone Hit 3-Year Low Prices Dec 24 2016 
    Asset Sales, New Projects Fuel 6.7% Yield Dec 07 2016 
    Robust Pipeline Supports 5.5% Dividend Yield Dec 05 2016 

    More From Other Websites
    Better Buy: Celldex Therapeutics, Inc. vs. Agenus Inc. May 21 2017
    Ionis (IONS) Stock Falls Despite Positive Inotersen Data May 16 2017
    Citi Prefers These 4 Stocks Over Pfizer On Bottom-Line Concerns May 16 2017
    Today's Research Reports on Stocks to Watch: GlaxoSmithKline and Novartis May 16 2017
    GlaxoSmithKline Could Buy Out Partner Novartis May 15 2017
    Top-10 Glaxo investor Woodford sells out, criticises board May 12 2017
    Glaxit: GlaxoSmithKline Sees a Top Investor Dump Stock out of 'Frustration' May 12 2017
    Woodford Turns Bullish on Lloyds as He Cuts Ties With Glaxo May 12 2017
    [$$] SuperGroup's wholesale change translates into sales May 11 2017
    Hikma Shares Plunge After It Says 'Low Likelihood' of 2017 Generic Advair Approval May 11 2017
    Mylan disagrees with FDA over generic Advair delay May 10 2017
    GlaxoSmithKline Plc : GSK-US: Dividend Analysis : May 12th, 2017 (record date) : By the numbers :... May 10 2017
    Better Buy: GlaxoSmithKline vs. Johnson & Johnson May 10 2017
    Which Big Pharma Is the Best Dividend Stock? May 06 2017
    GSK 'real world' drug test has second success in asthma May 05 2017
    Relvar Ellipta Significantly Improved Asthma Control in Salford Lung Study Patients Compared with... May 05 2017
    Here's What Wiped $3 Billion Off GlaxoSmithKline's Market Cap in April May 04 2017
    What’s GlaxoSmithKline’s Valuation after 1Q17 Earnings? May 03 2017
    Cambridge's bluebird bio licenses delivery tech to Novartis, GSK May 02 2017
    How GlaxoSmithKline’s Consumer Healthcare Segment Fared in 1Q17 May 02 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

    GF Chat